MICHAEL BEUS: Open Payments
NPI 1770569543 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 29 payments from 15 companies in 2025. Trend: 2023 $99 · 2024 $533 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $110 |
| PFIZER INC. | 3 | $63 |
| Inspire Medical Systems, Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Viatris Specialty LLC | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: QULIPTA, NURTEC ODT, INSPIRE, Auvelity, CAPLYTA, SHINGRIX, YUPELRI, EVENITY.
Industry payments across UT — which companies pay providers there.
